Navigation Links
Technology Innovation Provides Catalyst for Scientific Breakthroughs in Precision Medicine at World Molecular Imaging Congress

CULVER City, Calif., Sept. 16, 2013 /PRNewswire-USNewswire/ -- Leading companies in molecular imaging, life sciences, in vivo diagnostics, and the biotechnology and medical device industries will be showcasing state-of-the-art technologies and products at 6th World Molecular Imaging Congress (WMIC) in Savannah, GA September 18 – 21, 2013.  Combined with scientific breakthroughs in molecular imaging being presented at the WMIC, this innovation serves as a catalyst for advances in diagnostics and targeted therapy that support precision medicine.

"As the world's gathering place for all who are interested molecular imaging, the WMIC scientific program and technology showcase cover a broad spectrum of basic and translational research.  Our goal as a field is to optimize basic, preclinical and translational research leading to medical and molecular imaging discoveries, greater linkages between research and real world outcomes, and ultimately significant improvements in healthcare,"  said Anna Wu, President Elect of WMIS 2013-2014, Professor and Vice Chair, Department of Molecular and Medical Pharmacology,  UCLA. 

Participating companies include industry leaders such as Siemens, Agilent, PerkinElmer, Lilly, Bruker, and Mediso, with many unveiling new solutions in molecular imaging. Product introductions will include new contrast agents that can be used for both diagnostic and treatment guidance applications, imaging modalities, an open platform for preclinical ultrasound research and a preclinical microCT scanner.  Other innovations to be featured at WMIC include the demonstration of how mass spectrometry molecular imaging can be used for the identification and localization of the molecular products of all living cells. Several of the new developments and findings by these companies will be featured in nearly 50 clinical talks and posters presented at the Congress.

"WMIS commends our exhibitors for their  innovation and collaborations that help drive the progressive field of molecular imaging in support of more precise patient care," said Zaver Bhujwalla, Ph.D., WMIS President, and Professor, Radiology & Radiological Science, Oncology; Johns Hopkins University School of Medicine.


The WMIS is dedicated to developing and promoting translational research through multimodal molecular imaging. The education and abstract-driven WMIC annual meeting is held in conjunction with European Society for Molecular Imaging (ESMI) and Federation of Asian Societies for Molecular Imaging (FASMI). WMIC is the only meeting that provides a unique platform for scientists and clinicians with very diverse backgrounds to interact, present, and follow cutting-edge advances in molecular imaging.  Industry exhibits at the congress include the latest advances in preclinical and clinical imaging applications creating a complete molecular imaging educational technology showcase.

Contact: Christiaan Koop
Phone: 310-215-9730

SOURCE World Molecular Imaging Society
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
5. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
6. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
7. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
8. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
9. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
10. Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It?
11. INTAC™ Technology Combats Misuse of Extended Release Drugs
Post Your Comments:
(Date:11/30/2015)... 30, 2015   Nuance Communications, Inc. (NASDAQ: ... Support Company (NDSC) today jointly announced a new ... that utilize the American College of Radiology,s (ACR) Imaging ... to comply with current and emerging value-based payment ... --> By combining clinical decision support, radiology reporting ...
(Date:11/30/2015)... 30, 2015  Hanger, Inc. (NYSE: HGR ) ... the terms of its previously announced consent solicitation (as ... $200,000,000 aggregate principal amount 7⅛% Senior Notes due 2018 ... consent fees payable pursuant to the Consent Solicitation, (ii) ... (iii) the expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a ... for a child’s exposure limits. , The original Nov 2015 CR story titled, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Medicalis, a ... Radiology Society of North America (RSNA) annual meeting, being held November 29 – ... 2014. Throughout 2015, the company has completed installations for Integrated Delivery Network ...
(Date:11/30/2015)... , ... November 30, 2015 , ... It’s inevitable that ... family member, close friend, or animal pass away, death lives among us. It is ... , Coming from a family of 11 children, author T Sky understands that she ...
(Date:11/30/2015)... ... ... The successful filing of an Investigational New Drug application (IND) is a ... key industry segment, Regis Technologies has decided to sponsor and participate in an XTalks-hosted ... , Federal law does not allow new drugs to cross state lines until it ...
(Date:11/30/2015)... ... 2015 , ... Scott Newman MD, FACS of New York’s ... surgeons in the New York City area to utilize the new, non-invasive SculpSure™ ... laser treatment for fat loss in the abdomen, flanks, and other areas that ...
Breaking Medicine News(10 mins):